Doi.org/10.1074/jbc.M116.752493
Revision as of 08:17, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARchar(39) (peroxisome proliferator-activated receptor char(39)) and RUNX2 (runt-related transcription factor 2) ; Lance A Stechschulte Chunxi Ge Terry D Hinds Jr Edwin R Sanchez Renny T Franceschi Beata Lecka-; NULL; 09/29/2016; https://doi.org/10.1074/jbc.M116.752493 == Reasons == Note: Reasons not yet here included,...")
Target Article[edit | edit source]
Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARchar(39) (peroxisome proliferator-activated receptor char(39)) and RUNX2 (runt-related transcription factor 2) ; Lance A Stechschulte Chunxi Ge Terry D Hinds Jr Edwin R Sanchez Renny T Franceschi Beata Lecka-; NULL; 09/29/2016; https://doi.org/10.1074/jbc.M116.752493
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.